BRUSSELS – 8 October 2013 – COCIR today announces that Accuray Incorporated, a radiation oncology company has joined COCIR. 

Accuray develops and manufactures products designed to deliver the full range of radiation therapy and radiosurgery treatments, offering precise, clinically proven and innovative treatment to cancer patients.  Accuray’s two technologies, the CyberKnife® and the TomoTherapy® Systems are backed by a growing body of clinical evidence that support their use for the full spectrum of radiation oncology patient needs. 

“We are excited to have the opportunity to join COCIR.  We look forward to the ability to benefit from early monitoring of regulatory and technical aspects and to participate in their valuable market intelligence activities, as well as getting support in China through COCIR’s China Desk,” said Lionel Hadjadjeba, General Manager EIMEA & SVP International Business, of Accuray.

Nicole Denjoy, COCIR Secretary General added, “We are delighted to have Accuray onboard.  COCIR’s member companies provide products and services which play a vital role in healthcare.  Accuray is a key player in the field of Radiation Therapy (RT) which is used to treat a wide range of cancers by delivering highly-targeted radiation to cancerous cells, destroying their ability to grow and divide while leaving healthy cells intact.  Accuray’s technology fits very well within the innovative technologies COCIR represents through its membership.”

For more information, contact:

Nicole Denjoy           
COCIR Secretary General                   
Tel: +32 (0)2 706 8961      
denjoy@cocir.org              

Kathryn Sheridan
COCIR Communications Advisor
Tel: +32 (0)496 116198
press@cocir.org

About Accuray

Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumour treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com